# Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects

> **NCT01136317** · PHASE2 · COMPLETED · sponsor: **Nantes University Hospital**

## Conditions studied

- Gastroesophageal Reflux

## Interventions

- **DRUG:** Omeprazole
- **DRUG:** Rabeprazole
- **DRUG:** Lactose

## Key facts

- **NCT ID:** NCT01136317
- **Lead sponsor:** Nantes University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-04
- **Primary completion:** 2010-07
- **Final completion:** 2010-07
- **Target enrollment:** — (—)
- **Last updated:** 2010-09-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01136317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01136317, "Comparison of Antisecretory Effect of a Single Dose of Rabeprazole 20 mg and Omeprazole 20 mg in Obese Subjects". Retrieved via AI Analytics 2026-08-02 from https://api.ai-analytics.org/clinical/NCT01136317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*